PATENT CLAIM ANALYSIS

Application Number: 15991323
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "567000"]

Abstract:
Cyclopentene carboxylic acid-related compounds as GABA-AT inhibitors for treatment of various addictions, disorders and disease states.

Claim (Index 10):
The method of  claim 6  wherein said contact is in vivo.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15289480', '15586730', '13581187', '15712793', '15065487']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7715740626952063
- 35 USC 102 Novelty (BERT): 0.5606848511707073
- Combined Prediction Score: 0.7504851415427565
- Mean Citation Score: 336.6300520000001
- Max Citation Score: 448.89084
- Similarity Product: 289.712403474927

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test